Publications

Dalbavancin Disk Diffusion Tests: Development Evaluations Using Various Disk Concentrations, Solvents and Surfactants, Lead author: Jones RN, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Comparative Results of Oxacillin and Cefoxitin Disk Diffusion Staphylococcal Tests and the Occurrence of Inducible Clindamycin Resistance in Various Gram-Positive Species: Results from a 52-Center Trial of a Novel Lipopeptide, Lead author: Biedenbach DJ, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Re-Evaluation of Disk Diffusion Breakpoints for Tigecycline When Testing Enterobacteriaceae, Lead author: Sader HS, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Feasibility Studies for Anidulafungin Disk Diffusion Susceptibility Testing of Yeast by CLSI M-44 Method, Lead author: Rhomberg PR, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Molecular Analysis of Resistance Markers and Clonality among Gram-negative Bacilli: Report from the 2006 MYSTIC Program (USA), Lead author: Deshpande LM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Community-Acquired Respiratory Tract Infections (CA-RTI) in Europe Caused by S. pneumoniae (SPN), H. influenzae (HI) and M. catarrhalis (MCAT): Report from 10 Years of Monitoring by the SENTRY Program, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Increasing Prevalence of Glycopeptide Hetero-resistant S. aureus (hGISA) from the Detroit Metropolitan Area over a 20-year period (1986-2006), Lead author: Rybak M, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Linezolid Against a Worldwide Collection of Uncommonly Isolated Gram-positive Organisms (3,251 strains), Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Differential Propensity of Serotype Groups to Switch and Acquire Multidrug-Resistance after the Introduction of the Pneumococcal Conjugate Vaccine in the United States, Lead author: Mera RM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

10 Years of Surveillance of Bloodstream Infections in European Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Occurrence and Susceptibility (S) Rates Among Urinary Tract Infection Pathogens from Europe: A Seven Year Report from the SENTRY Antimicrobial Surveillance Program (1997-2000, 2003), Lead author: Moet G, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolated in Two Turkish Medical Centers in 2006: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Accuracy of Beta-Lactam Susceptibility Testing Results from Vitek and Vitek 2 Systems when Testing Pseudomonas aeruginosa, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Critical Assessment of P. aeruginosa (PSA) Susceptibility Testing Results for Six Beta-Lactams Using the BD Phoenix System, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

An Evaluation of MicroScan WalkAway Results for Broad-Spectrum Beta-Lactams When Testing Pseudomonas aeruginosa (PSA), Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Evaluation of the In Vitro Activity of Levofloxacin and Moxifloxacin Tested Against Stenotrophomonas maltophilia: Can Moxifloxacin Activity Be Predicted by Levofloxacin MIC Results?, Lead author: Gales AC, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Susceptibility Analysis of Gastroenteritis and Beta-Haemolytic Streptococcal Pathogens Collected During a Decade of SENTRY Antimicrobial Surveillance Program Monitoring in Europe (1997-2006), Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence and Antimicrobial Susceptibility (S) Profiles of Skin and Skin Structure Infection (SSSI) Pathogens in Europe (EUR): Report from the SENTRY Antimicrobial Surveillance Program (1997-2005), Lead author: Ross JE, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Resistance Rates Among Selected Gram-positive and -negative Isolates from European (EU) Medical Centers: A Decade of SENTRY Program Surveillance (1997-2006), Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Update on Potency and Spectrum of Activity of Meropenem (MEM) and Selected Broad-Spectrum Agents: Testing Results from the USA MYSTIC Program (2006), Lead author: Rhomberg PR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Update on Daptomycin Activity and Spectrum When Tested Against Gram-Positive Strains Collected in European Medical Centers (2006), Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Daptomycin and Selected Antimicrobial Agents Tested against Gram-positive Organisms Isolated from European Patients with Complicated Skin and Skin Structure Infections (cSSSI), Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Trends in Species Distributions and Susceptibilities of Fungal Pathogens Recovered from European Medical Centers: A Report from the SENTRY Antimicrobial Surveillance Program (1999-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Antimicrobial Activity of Tigecycline and Other Broad-Spectrum Agents Tested Against Bacterial Isolates Collected in European Hospitals in 2006, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Evaluation of Expected Clinical Success Rates of Tigecycline and Other Commonly Used Antimicrobials for Empiric Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in Germany, Spain and the United States, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Spectrum and Activity of Doripenem, an Investigational Carbapenem, Tested Against Bacterial Pathogens Recovered from Patients Hospitalized with Pneumonia (Europe; 2004-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Variations and Trends in the Activity of Doripenem and Other Broad-Spectrum Agents Against Leading Bacterial Pathogens: Results from a European Surveillance Program (2003-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence of Confirmed ESBL-Production among European Enterobacteriaceae: A Ten Year Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Emergence and Dissemination of Metallo-Beta-Lactamases Producing Strains in Europe: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Assessment of the Polymyxin B Antimicrobial Activity Tested against 26,921 Clinical Strains of Gram-Negative Bacilli Collected in Europe: Report from 10 Years of the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Characterization VIM-1-Producing Pseudomonas aeruginosa, Enterobacter cloacae and Klebsiella pneumoniae Strains from Germany: Report from SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

The Evaluation of the Bactericidal Activity of Daptomycin, Vancomycin and Linezolid and determination of the Interactions of These Antimicrobials with Gentamicin or Rifampin against S. aureus, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence and Antimicrobial Susceptibility Profiles of Leading Nosocomial Pneumonia Pathogens: The Ten Year Report from the European SENTRY Antimicrobial Surveillance Program, Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

High-Level Multidrug-Resistance (MDR) Among Viridians Group Streptococci Isolated from Turkey: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Ceftobiprole Tested Against Contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Ceftobiprole Tested Against Staphylococcal and Streptococcal Isolates Recovered from Patients in European Medical Centers (2005-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Dalbavancin Activity Tested Against Rarely Isolated Gram-positive Organism Species from Europe, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Antimicrobial Activity of Tigecycyline (TGC) Tested Against Contemporary Bacterial Isolates Collected in European Hospitals, Lead author: Jones RN, presented at 6th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 7 – 9, 2007, Raffles City Convention Center, Singapore

Activity of Tigecycline (TGC) When Tested Against Gram-positive (GP) Pathogens in North American (NA) Hospitals (2006), Lead author: Jones RN, presented at 6th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 7 – 9, 2007, Raffles City Convention Center, Singapore

Activity of ceftobiprole tested against staphylococci and streptococci in the Asia-Pacific region: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Bell JM, presented at 6th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 7 – 9, 2007, Raffles City Convention Center, Singapore

Doripenem (DOR) activity against leading bacterial pathogens in the Asia-Pacific region: Report from the SENTRY Antimicrobial Surveillance Program, 2006, Lead author: Bell JM, presented at 6th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 7 – 9, 2007, Raffles City Convention Center, Singapore

Tigecycline Antimicrobial Susceptibility Testing in the Asia-Pacific (APAC) Region: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Bell JM, presented at 6th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 7 – 9, 2007, Raffles City Convention Center, Singapore

Tigecycline (TGC) Potency and Spectrum When Tested Against Gram-negative Pathogens from North American Medical Centers (2006), Lead author: Jones RN, presented at 6th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 7 – 9, 2007, Raffles City Convention Center, Singapore

Oxazolidinone susceptibility patterns for 2005: International report from the Zyvox®; Annual Appraisal of Potency and Spectrum Study. by Ross JE, Fritsche TR, Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2007; 29 (3): 295-301

bla_VIM-2 and bla_VIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: Report from the MYSTIC Program. by Aboufaycal H, Sader HS, Deshpande LM, Toleman M, Bodey G, Raad I and Jones RN published in J. Clin. Microbiol. 2007; 45: 614-615

Cefdinir: An oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. by Sader HS and Jones RN published in Expert Rev. Anti. Infect. Ther. 2007; 5 (1): 29-43

Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC Program report from the Unite States component (2005). by Rhomberg PR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 57 (2): 207-215

Multicenter studies of tigecycline disk diffusions susceptibility results for Acinetobacter spp. by Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM and Sader HS published in J. Clin. Microbiol. 2007; 45 (1): 227-230

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 7-13

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Jones RN, Sader HS, Fritsche TR and Pottumarthy S published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 109-116